packageSerplulimab

serplulimab

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Serplulimab is a monoclonal antibody that blocks PD-1 and is used to treat lung cancers, including small cell and non-small cell lung carcinoma, and esophageal squamous cell carcinoma. It is an approved anticancer medicine with one product authorised in the European Union, and remains under investigation for further uses.

Summary written by glm-5.3-flash from Wikidata Q130351954 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:serplulimab
ATC codes:L01FF12
DrugBank:DB17451
Wikidata:Q130351954

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown